95 related articles for article (PubMed ID: 29346129)
1. High Inflammatory Infiltrate Correlates With Poor Symptomatic Improvement After Surgical Treatment for Superior Limbic Keratoconjunctivitis.
Zoroquiain P; Sanft DM; Esposito E; Cheema D; Dias AB; Burnier MN
Cornea; 2018 Apr; 37(4):495-500. PubMed ID: 29346129
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival resection combined with tenon layer excision and the involvement of mast cells in superior limbic keratoconjunctivitis.
Sun YC; Hsiao CH; Chen WL; Wang IJ; Hou YC; Hu FR
Am J Ophthalmol; 2008 Mar; 145(3):445-452. PubMed ID: 18201682
[TBL] [Abstract][Full Text] [Related]
3. Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease.
Sivaraman KR; Jivrajka RV; Soin K; Bouchard CS; Movahedan A; Shorter E; Jain S; Jacobs DS; Djalilian AR
Ocul Surf; 2016 Jul; 14(3):393-400. PubMed ID: 27179980
[TBL] [Abstract][Full Text] [Related]
4. Superior limbic keratoconjunctivitis: a comprehensive review.
Lahoti S; Weiss M; Johnson DA; Kheirkhah A
Surv Ophthalmol; 2022; 67(2):331-341. PubMed ID: 34077767
[TBL] [Abstract][Full Text] [Related]
5. New surgical treatment for superior limbic keratoconjunctivitis and its association with conjunctivochalasis.
Yokoi N; Komuro A; Maruyama K; Tsuzuki M; Miyajima S; Kinoshita S
Am J Ophthalmol; 2003 Mar; 135(3):303-8. PubMed ID: 12614746
[TBL] [Abstract][Full Text] [Related]
6. Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva.
Udell IJ; Kenyon KR; Sawa M; Dohlman CH
Ophthalmology; 1986 Feb; 93(2):162-6. PubMed ID: 3951822
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin and proliferative cell nuclear antigen expression in superior limbic keratoconjunctivitis.
Matsuda A; Tagawa Y; Matsuda H
Curr Eye Res; 1996 Oct; 15(10):1033-8. PubMed ID: 8921242
[TBL] [Abstract][Full Text] [Related]
8. Tear cytokine profiling in patients with superior limbic keratoconjunctivitis who underwent medical treatment or in conjunction with surgical management.
Sun YC; Tang YH; Liou HM; Chen WL; Hu FR
Br J Ophthalmol; 2020 May; 104(5):735-740. PubMed ID: 30926588
[TBL] [Abstract][Full Text] [Related]
9. Development of superior limbic keratoconjunctivitis after upper eyelid blepharoplasty surgery: support for the mechanical theory of its pathogenesis.
Sheu MC; Schoenfield L; Jeng BH
Cornea; 2007 May; 26(4):490-2. PubMed ID: 17457203
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of superior limbic keratoconjunctivitis using laser scanning confocal microscopy and conjunctival impression cytology.
Kojima T; Matsumoto Y; Ibrahim OM; Sato EA; Dogru M; Tsubota K
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3986-92. PubMed ID: 20375341
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta2, tenascin, and integrin beta1 expression in superior limbic keratoconjunctivitis.
Matsuda A; Tagawa Y; Matsuda H
Jpn J Ophthalmol; 1999; 43(4):251-6. PubMed ID: 10482468
[TBL] [Abstract][Full Text] [Related]
12. Clinical Severity Classification using Automated Conjunctival Hyperemia Analysis Software in Patients with Superior Limbic Keratoconjunctivitis.
Kurita J; Shoji J; Inada N; Yoneda T; Sumi T; Kobayashi M; Hoshikawa Y; Fukushima A; Yamagami S
Curr Eye Res; 2018 Jun; 43(6):679-682. PubMed ID: 29336627
[TBL] [Abstract][Full Text] [Related]
13. Recharacterization of superior limbic keratoconjunctivitis via a subdividing grading method in 236 Chinese patients.
Cheng C; Zhu M; Lin T; Chen Z; Zeng W; Li K; Xue R; Duan F; Wu K
Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2291-2298. PubMed ID: 35113250
[TBL] [Abstract][Full Text] [Related]
14. Lacrimal occlusion therapy for the treatment of superior limbic keratoconjunctivitis.
Kabat AG
Optom Vis Sci; 1998 Oct; 75(10):714-8. PubMed ID: 9798210
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell Factor and Thymic Stromal Lymphopoietin Overexpression With Correlation to Mast Cells in Superior Limbic Keratoconjunctivitis.
Sun YC; Liou HM; Shen EP; Hu FR
Cornea; 2015 Nov; 34(11):1487-92. PubMed ID: 26382891
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
Rodriguez-Garcia A; Macias-Rodriguez Y; Gonzalez-Gonzalez JM
Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
[TBL] [Abstract][Full Text] [Related]
17. Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis.
Shen YC; Wang CY; Tsai HY; Lee YF
Cornea; 2007 May; 26(4):423-6. PubMed ID: 17457190
[TBL] [Abstract][Full Text] [Related]
18. Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
Takahashi Y; Ichinose A; Kakizaki H
Am J Ophthalmol; 2014 Apr; 157(4):807-812.e2. PubMed ID: 24412123
[TBL] [Abstract][Full Text] [Related]
19. The fine structure of nuclear changes in superior limbic keratoconjunctivitis.
Collin HB; Donshik PC; Boruchoff SA; Foster CS; Cavanagh HD
Invest Ophthalmol Vis Sci; 1978 Jan; 17(1):79-84. PubMed ID: 621134
[TBL] [Abstract][Full Text] [Related]
20. Superior limbic keratoconjunctivitis in association with scarring of the superior tarsal conjunctiva.
Raber IM
Cornea; 1996 May; 15(3):312-6. PubMed ID: 8713936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
